Work with thought leaders and academic experts in Hematology
Companies can greatly benefit from collaborating with academic researchers in the field of Hematology. These experts bring a wealth of knowledge and experience that can enhance research, development, and innovation in various ways. Here are some key reasons why companies would want to collaborate with Hematology researchers: 1. Cutting-edge Research: Hematology researchers are at the forefront of scientific advancements in blood disorders and diseases. Collaborating with them can provide access to the latest research findings and breakthroughs. 2. Expertise in Clinical Trials: Hematology researchers have extensive experience in conducting clinical trials for new treatments and therapies. Partnering with them can accelerate the development and testing of new drugs. 3. Access to Specialized Equipment: Hematology researchers often have access to state-of-the-art equipment and facilities. Collaborating with them can provide companies with access to advanced technologies for research and development. 4. Collaboration on Publications: Working with Hematology researchers can lead to joint publications in reputable scientific journals. This can enhance the company's reputation and credibility in the field. 5. Networking Opportunities: Collaborating with Hematology researchers allows companies to expand their professional network and establish connections with other experts in the field. By collaborating with academic researchers in Hematology, companies can tap into a vast pool of knowledge and expertise, leading to improved research outcomes and potential commercial success.
Researchers on NotedSource with backgrounds in Hematology include Garrett A. Perchetti, Research Scientist - Virology, Burcu Vitrinel, Ph.D., Elvira Forte, Boris Leibovitch, Ping Luo, Dr. Everson A Nunes, Ph.D., Dushani L. Palliyaguru, Ph.D., John M Baust, Ph.D, Jeffrey Townsend, Khoa Nguyen, Luke Connelly, Thaddeus Allen, and Mohsen Fathzadeh.
Garrett A. Perchetti, Research Scientist - Virology
Research Scientist and MD Candidate in virology with publications on infectious diseases, laboratory medicine, viral genetics, and clinical medicine
Most Relevant Research Expertise
Other Research Expertise (14)
About
Most Relevant Publications (1+)
28 total publications
Cytomegalovirus breakthrough and resistance during letermovir prophylaxis
Bone Marrow Transplantation / Jan 24, 2023
Perchetti, G. A., Biernacki, M. A., Xie, H., Castor, J., Joncas-Schronce, L., Ueda Oshima, M., Kim, Y., Jerome, K. R., Sandmaier, B. M., Martin, P. J., Boeckh, M., Greninger, A. L., & Zamora, D. (2023). Cytomegalovirus breakthrough and resistance during letermovir prophylaxis. Bone Marrow Transplantation, 58(4), 430–436. https://doi.org/10.1038/s41409-023-01920-w
See Full Profile
Elvira Forte
Scientific strategist • Senior Scientist • Senior Scientific Editor
Most Relevant Research Expertise
Other Research Expertise (26)
About
Most Relevant Publications (2+)
63 total publications
TGFβ-Dependent Epithelial-to-Mesenchymal Transition Is Required to Generate Cardiospheres from Human Adult Heart Biopsies
Stem Cells and Development / Nov 20, 2012
Forte, E., Miraldi, F., Chimenti, I., Angelini, F., Zeuner, A., Giacomello, A., Mercola, M., & Messina, E. (2012). TGFβ-Dependent Epithelial-to-Mesenchymal Transition Is Required to Generate Cardiospheres from Human Adult Heart Biopsies. Stem Cells and Development, 21(17), 3081–3090. https://doi.org/10.1089/scd.2012.0277
New Perspectives to Repair a Broken Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry / Apr 01, 2009
Gaetani, R., Barile, L., Forte, E., Chimenti, I., Ionta, V., Di Consiglio, A., Miraldi, F., Frati, G., Messina, E., & Giacomello, A. (2009). New Perspectives to Repair a Broken Heart. Cardiovascular & Hematological Agents in Medicinal Chemistry, 7(2), 91–107. https://doi.org/10.2174/187152509787847128
See Full Profile
Boris Leibovitch
Experienced wet lab and in teaching Molecular Cell biologist, geneticist, cancer biologist in Academia
Most Relevant Research Expertise
Other Research Expertise (8)
About
Most Relevant Publications (1+)
22 total publications
The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor
Blood / Mar 15, 2008
Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M.-M., Waxman, S., Leibovitch, B. A., Walsh, M. J., & Licht, J. D. (2008). The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood, 111(6), 3145–3154. https://doi.org/10.1182/blood-2007-06-092122
See Full Profile
Ping Luo
Bioinformatics Specialist at Princess Margaret Cancer Centre with experience in deep learning
Most Relevant Research Expertise
Other Research Expertise (21)
About
Most Relevant Publications (1+)
23 total publications
Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma
Blood / Nov 05, 2021
Coffey, D. G., Maura, F., Gonzalez-Kozlova, E., Diaz-Mejia3, J., Luo, P., Zhang, Y., Xu, Y., Warren, E. H., Smith, E. L., Cho, H. J., Lesokhin, A., Diamond, B., Kazandjian, D., Pugh, T. J., Green, D. J., Gnjatic, S., & Landgren, O. (2021). Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma. Blood, 138(Supplement 1), 329–329. https://doi.org/10.1182/blood-2021-154506
See Full Profile
Dr. Everson A Nunes, Ph.D.
Post-Doctoral Fellow at McMaster University | former Associate Professor - Physiological Sciences
Most Relevant Research Expertise
Other Research Expertise (39)
About
Most Relevant Publications (1+)
97 total publications
Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms
Revista Brasileira de Hematologia e Hemoterapia / Jan 01, 2013
Betiati, D. da S. B., Oliveira, P. F. de, Camargo, C. de Q., Nunes, E. A., & Trindade, E. B. S. de M. (2013). Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms. Revista Brasileira de Hematologia e Hemoterapia, 35(2). https://doi.org/10.5581/1516-8484.20130033
See Full Profile
Dushani L. Palliyaguru, Ph.D.
Toxicologist | Aging, Nutrition and Metabolism Research Scientist | Systems Biologist
Most Relevant Research Expertise
Other Research Expertise (16)
About
Most Relevant Publications (1+)
20 total publications
Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane
Seminars in Oncology / Feb 01, 2016
Yang, L., Palliyaguru, D. L., & Kensler, T. W. (2016). Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. Seminars in Oncology, 43(1), 146–153. https://doi.org/10.1053/j.seminoncol.2015.09.013
See Full Profile
John M Baust, Ph.D
Proven success in delivering best-in-class services across scientific, commercial and education environments.
Most Relevant Research Expertise
Other Research Expertise (16)
About
Most Relevant Publications (1+)
68 total publications
Dose Escalation of Vitamin D3 Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model
Cancer Control / Jan 01, 2018
Santucci, K. L., Baust, J. M., Snyder, K. K., Van Buskirk, R. G., & Baust, J. G. (2018). Dose Escalation of Vitamin D3 Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model. Cancer Control, 25(1), 107327481875741. https://doi.org/10.1177/1073274818757418
See Full Profile
Jeffrey Townsend
Professor of Biostatistics and Ecology & Evolutionary Biology
Most Relevant Research Expertise
Other Research Expertise (52)
About
Most Relevant Publications (3+)
207 total publications
Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia
Leukemia / Nov 11, 2022
Mandell, J. D., Fisk, J. N., Cyrenne, E., Xu, M. L., Cannataro, V. L., & Townsend, J. P. (2022). Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia. Leukemia, 36(12), 2931–2933. https://doi.org/10.1038/s41375-022-01752-5
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
Annals of Oncology / Jan 01, 2017
Choi, M., Kadara, H., Zhang, J., Parra, E. R., Rodriguez-Canales, J., Gaffney, S. G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Kim, K., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D. L., Heymach, J., Kaftan, E., Townsend, J. P., … Wistuba, I. I. (2017). Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function. Annals of Oncology, 28(1), 83–89. https://doi.org/10.1093/annonc/mdw437
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
Annals of Oncology / Jan 01, 2017
Kadara, H., Choi, M., Zhang, J., Parra, E. R., Rodriguez-Canales, J., Gaffney, S. G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Yoo, Y., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D. L., Heymach, J., Kaftan, E., Townsend, J. P., … Herbst, R. S. (2017). Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Annals of Oncology, 28(1), 75–82. https://doi.org/10.1093/annonc/mdw436
See Full Profile
Khoa Nguyen
Life Sciences Expert with 18-Year Experience in Immunology, Metabolism, Neuroscience, and Biotech Entrepreuneuship
Most Relevant Research Expertise
Other Research Expertise (25)
About
Most Relevant Publications (1+)
47 total publications
Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways
Blood / Apr 07, 2011
Nguyen, K. D., Macaubas, C., Nadeau, K. C., Truong, P., Yoon, T., Lee, T., Park, J. L., & Mellins, E. D. (2011). Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways. Blood, 117(14), 3793–3798. https://doi.org/10.1182/blood-2010-11-318832
See Full Profile
Luke Connelly
Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Expertise
Other Research Expertise (42)
About
Most Relevant Publications (1+)
105 total publications
An economic evaluation of plasma production via erythroplasmapheresis and whole blood collection
Transfusion and Apheresis Science / Oct 01, 2002
Connelly, L. B., & Pink, A. (2002). An economic evaluation of plasma production via erythroplasmapheresis and whole blood collection. Transfusion and Apheresis Science, 27(2), 101–111. https://doi.org/10.1016/s1473-0502(02)00046-0
See Full Profile
Thaddeus Allen
Professional who facilitates science, strategy and team building in biotech with a knack for deconstructing complexity to provide insight and direction.
Most Relevant Research Expertise
Other Research Expertise (24)
About
Most Relevant Publications (1+)
50 total publications
TALE Homeoproteins as HOX11-Interacting Partners in T-cell Leukemia
Leukemia & Lymphoma / Jan 01, 2000
Allen, T. D., Zhlp, Y.-X., Hawley, T. S., & Hawley, R. G. (2000). TALE Homeoproteins as HOX11-Interacting Partners in T-cell Leukemia. Leukemia & Lymphoma, 39(3–4), 241–256. https://doi.org/10.3109/10428190009065824
See Full Profile
Mohsen Fathzadeh
Research Scientist, Genomics, Stanford University
Most Relevant Research Expertise
Other Research Expertise (16)
About
Most Relevant Publications (1+)
30 total publications
Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major
Haematologica / Feb 01, 2007
Bazrgar, M., Karimi, M., Peiravian, F., & Fathzadeh, M. (2007). Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major. Haematologica, 92(2), 256–257. https://doi.org/10.3324/haematol.10708
See Full Profile
Example Hematology projects
How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Hematology?
Development of Novel Hematology Diagnostic Tool
A company in the medical device industry can benefit from collaborating with a Hematology researcher to develop a novel diagnostic tool for blood disorders. The researcher's expertise in analyzing blood samples and identifying specific markers can contribute to the development of an accurate and efficient diagnostic device.
Drug Discovery for Hematological Cancers
A pharmaceutical company focused on oncology can collaborate with a Hematology researcher to discover new drugs for hematological cancers. The researcher's deep understanding of the molecular mechanisms involved in blood cancers can guide the development of targeted therapies.
Improving Blood Transfusion Practices
A healthcare organization can partner with a Hematology researcher to improve blood transfusion practices. The researcher's knowledge of blood compatibility, transfusion reactions, and storage techniques can help optimize transfusion protocols and ensure patient safety.
Development of Gene Therapies for Hemophilia
A biotechnology company can collaborate with a Hematology researcher to develop gene therapies for hemophilia. The researcher's expertise in gene editing and delivery systems can contribute to the development of innovative treatments for this genetic blood disorder.
Exploring Stem Cell Therapies for Blood Disorders
A regenerative medicine company can work with a Hematology researcher to explore the potential of stem cell therapies for blood disorders. The researcher's knowledge of hematopoietic stem cells and their differentiation can aid in developing novel therapeutic approaches.